Educational Program Offerings
- Guts & Glory: Colorectal Screening Options
In this workshop, you will learn how most colorectal cancers can be prevented through screening. You will learn about different screening options and testing as well as when you should start screening.
- Nutrition for Colorectal Health
In this workshop, you will learn about the risk factors for colorectal cancer as well as current screening recommendations for cancer prevention. You will also learn about eating habits that can reduce your risk of colorectal cancer through a healthy lifestyle and eating pattern.
- Eating for Cancer Prevention
In this workshop, you will learn how foods can promote your health while protecting your body from cancer. You will learn how to portion your plate with different foods to boost your health.
- Community CARES (Cancer Action Resource Education Series)
In this learning series designed for community health workers, patient navigators, health educators and community advocates, participants learn about the process of cancer initiation and growth, how nutrition can prevent cancer, best practices for patient navigation, current up-dates on HPV vaccination as well as next steps for clinical trials and research in our communities.
Upcoming Educational Events
News You Can Use
- National Colorectal Cancer Roundtable: A Playbook for Reigniting Colorectal Cancer Screening as Communities Respond to the COVID-19 Pandemic
- Summary Report On Link of Care Pilot to Increase Colorectal Cancer Screening for Underserved Patients
- Fight Colorectal Cancer: Colorectal Cancer in Young Adults
- Alliance A021703: Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
This study focusing on colorectal cancer, in partnership with Solaris, compares the progression-free survival (PFS) of patients receiving high-dose vitamin D3 in combination with standard chemotherapy and bevacizumab versus those receiving standard-dose vitamin D3 in combination with standard chemotherapy and bevacizumab.